Cheng‐Yi Wang
Cheng‐Yi Wang publishes mostly in Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology, on topics such as Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases and Respiratory Support and Mechanisms.
- World rank
- #1,256,029 of 7,710,434 ranked researchers
- Rank in Taiwan
- #6,476 of 57,035
- Works
- 134
- Citations
- 4.3k
- Citations per work
- 32.3
What does Cheng‐Yi Wang research?
Cheng‐Yi Wang's work is mostly in Medicine (48%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6548.5%
- Medicine6548.5%
- Everything else6347.3%
- Life Sciences64.2%
- 1Pulmonary and Respiratory Medicine24% of their works
- 2Infectious Diseases8% of their works
- 3Epidemiology7% of their works
- 4Physiology5% of their works
- 5Molecular Biology4% of their works
- 6Oncology4% of their works
Research topics
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Asthma and respiratory diseases
- Respiratory Support and Mechanisms
- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Inhalation and Respiratory Drug Delivery
- SARS-CoV-2 and COVID-19 Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Which keywords describe Cheng‐Yi Wang's research?
The keywords of their largest research topics: Epidemiology, COPD, spirometry, ACE2 Receptor, SARS-CoV-2, Acute Lung Injury, Allergic Diseases and Asthma.
- Idiopathic Pulmonary Fibrosis
- Coronavirus
- Post-acute COVID-19 Syndrome
- Inhaler Devices
- Clinical Characteristics
- Asthma
- Acute Lung Injury
- ACE2 Receptor
- COPD
- Epidemiology
- spirometry
- SARS-CoV-2
- Allergic Diseases
- Mechanical Ventilation
- Thrombosis
- Neurologic Manifestations
- Pulmonary Drug Delivery
- Fibrosis
- Vaccine
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Epidemiology272 topics
- COPD261 topic
- spirometry261 topic
- ACE2 Receptor192 topics
- SARS-CoV-2192 topics
- Acute Lung Injury151 topic
- Allergic Diseases151 topic
- Asthma151 topic
- Mechanical Ventilation151 topic
- Clinical Characteristics121 topic
- Thrombosis121 topic
- Inhaler Devices81 topic
- Neurologic Manifestations81 topic
- Post-acute COVID-19 Syndrome81 topic
- Pulmonary Drug Delivery81 topic
- Coronavirus71 topic
- Fibrosis71 topic
- Idiopathic Pulmonary Fibrosis71 topic
- Vaccine71 topic
Where does Cheng‐Yi Wang work?
Cheng‐Yi Wang's main affiliation in the publication record is Cardinal Tien Hospital, Taiwan.
How many publications and citations does Cheng‐Yi Wang have?
OpenAlex counts 134 works and 4,331 citations for Cheng‐Yi Wang, an h-index of 30, ranking #1,256,029 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Cheng‐Yi Wang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.